Rozman K, Hazelton G A, Klaassen C D, Arlotto M P, Parkinson A
Toxicology. 1985 Oct;37(1-2):51-63. doi: 10.1016/0300-483x(85)90112-x.
The effect of thyroidectomy and thyroid hormone replacement therapy on liver microsomal enzyme induction was studied in 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats (100 micrograms/kg). Treatment of non-thyroidectomized rats with TCDD had no effect on the concentration of liver microsomal cytochrome b5. In contrast, cytochrome b5 content was increased by TCDD treatment of thyroidectomized rats, regardless of replacement therapy with either T3 or T4. TCDD treatment increased the concentration of cytochrome P-450 (2-3-fold) and the activities of benzo[a]pyrene hydroxylase (4-7-fold), ethoxyresorufin O-de-ethylase (50-70-fold) and UDP-glucuronosyltransferase (5-7-fold) in non-thyroidectomized and thyroidectomized as well as thyroidectomized thyroid hormone treated rats; indicating the induction of these liver microsomal enzyme activities is independent of thyroid status. Because thyroid status alters the toxicity of TCDD but does not alter the ability of TCDD to induce microsomal enzymes, it appears that TCDD toxicity may not be directly related to microsomal enzyme induction.
在给予2,3,7,8 - 四氯二苯并 - p - 二噁英(TCDD,100微克/千克)处理的大鼠中,研究了甲状腺切除术和甲状腺激素替代疗法对肝脏微粒体酶诱导的影响。用TCDD处理未进行甲状腺切除的大鼠,对肝脏微粒体细胞色素b5的浓度没有影响。相反,无论用T3还是T4进行替代疗法,TCDD处理甲状腺切除的大鼠都会增加细胞色素b5的含量。TCDD处理增加了未进行甲状腺切除、甲状腺切除以及甲状腺切除并接受甲状腺激素治疗的大鼠中细胞色素P - 450的浓度(2 - 3倍)、苯并[a]芘羟化酶的活性(4 - 7倍)、乙氧基异吩唑酮 - O - 脱乙基酶的活性(50 - 70倍)以及UDP - 葡萄糖醛酸基转移酶的活性(5 - 7倍);这表明这些肝脏微粒体酶活性的诱导与甲状腺状态无关。由于甲状腺状态会改变TCDD的毒性,但不会改变TCDD诱导微粒体酶的能力,因此似乎TCDD的毒性可能与微粒体酶的诱导没有直接关系。